RG1 antibodies and uses thereof

Details RG1 antibodies and uses thereof RG1 antibodies and uses thereof

2007-10-30

2009-10-27

Blanchard, David J. (Department: 1643)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Monoclonal antibody or fragment thereof

C424S130100, C424S141100, C424S155100, C424S181100, C435S069600, C435S070210, C530S387100, C530S388100, C530S388150, C530S388800, C530S391300, C530S391700

Reexamination Certificate

active

07608263

ABSTRACT:
The present invention relates to antibodies, and antigen-binding antibody fragments, directed against an RG1 polypeptide. The invention further relates to methods for utilizing the antibodies, and antibody fragments, for diagnostic and therapeutic applications.

REFERENCES:
patent: 4831175 (1989-05-01), Gansow et al.
patent: 5246692 (1993-09-01), Gansow et al.
patent: 5804382 (1998-09-01), Sytkowski et al.
patent: 5871969 (1999-02-01), Hastings et al.
patent: 5877397 (1999-03-01), Lonberg et al.
patent: 6150584 (2000-11-01), Kucherlapati et al.
patent: 6300129 (2001-10-01), Lonberg et al.
patent: 6682736 (2004-01-01), Hanson et al.
patent: 6682902 (2004-01-01), Harkins et al.
patent: 6824780 (2004-11-01), Devaux et al.
patent: 2003/0059427 (2003-03-01), Force et al.
patent: 2004/0120948 (2004-06-01), Mikayama et al.
patent: 1 262 193 (2002-12-01), None
patent: WO98/45442 (1998-10-01), None
patent: WO98/50073 (1998-11-01), None
patent: WO99/46281 (1999-09-01), None
patent: WO00/23108 (2000-04-01), None
patent: WO01/44291 (2001-06-01), None
patent: WO02/088186 (2002-11-01), None
patent: WO03/031475 (2003-04-01), None
Umemiya et al., “M-Spondin, a novel ECM protein highly homologous to vertebrate F-spondin, is localized at the muscle attachment sites in the Drosophila embryo,”Develop. Biol., 1997, 186:165-76 (Exhibit 9).
Manda et al., “Identification of genes (SPON2 and C2Oorf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display,”Genomics, 1999, 61:5-14 (Exhibit 10).
Klar et al., “F-spondin: a gene expressed at high levels in the floor plate encodes a secreted protein that promotes neural cell adhesion and neurite extension,”Cell, 1992, 69:95-110 (Exhibit 11).
Feinstein et al., “F-spondin and mindin: two structurally and functionally related genes expressed in the hippocampus that promote outgrowth of embryonic hippocampal neurons,”Development, 1999, 126:3637-48 (Exhibit 12).
Burstyn-Cohen et al., “Accumulation of F-spondin in injured peripheral nerve promotes the outgrowth of sensory axons,”J. Neuroscience, 1998, 18:8875-85 (Exhibit 13).
Higashijima et al., Mindin/F-Spondin Family: Novel ECM Proteins Expressed in the Zebrafish Embryoic Axis,Developmental Biology, 1997, 192:211-27 (Exhibit 14).
Sodee et al., “Preliminary Imaging Results Using In-11 Labeled CYT-356 (Prostascint™) in the Detection of Recurrent Prostate Cancer,”Clinical Nuclear Medicine, 1996, 21:759-67 (Exhibit 15).
Mikayama et al., “Molecular cloning and functional expression of cDNA encoding glycosylation-inhibiting factor,”PNAS, 1993, 90:10056-60 (Exhibit 16).
Ngo et al., “Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox,” inThe Protein Folding Problem and Tertiary Structure Prediction, 1994, ed. Birkhauser, Boston, MA, pp. 433 and 492-5 (Exhibit 17).
Saini et al., “Regulation of the turnover of mRNAs encoding cellular oncoproteins,”Biochem. Cell Biol., 1991, 69:415-7 (Exhibit 18).
Hershey, “Protein Phosphorylation Controls Transition Rates,”J. Biol. Chem., 1989, 264:20832-6 (Exhibit 19).
Fan, Z-H et al., “Enhancement of Nitric Oxide Production from Activated Macrophages by Purified Form of Ginsenoside (RG1),”The Great American Journal of Chinese Medicine, 1995, 23:279-87 (Exhibit 26).
Borrebaeck, Carl A. K. et al., “Kinetic Analysis of Recombinant Antibody—Antigen Interactions: Relation Between Structural Domains and Antigen Binding,”Bio/Technology, 1992, 10:697-8 (Exhibit 27).
Little, M. et al., “Of mice and men: hybridoma and recombinant antibodies,”Immunology Today, 2000, 21:364-70 (Exhibit 28).
Fundamental Immunology, William E. Paul, ed., New York, NY, 1993, pp. 292-5 (Exhibit 33).
Rudikoff, Stuart et al., “Single amino acid substitution altering antigen-binding specificity,”Proc. Natl. Acad. Sci. USA, 1982, 79:1979-83 (Exhibit 34).
Colman, P. M., “Effects of amino acid sequence changes on antibody-antigen interactions,”Research in Immunology, 1994, 145:33-6 (Exhibit 35).
Holliger, Philipp et al., “Diabodies': Small bivalent and bispecific antibody fragments,”Proc. Natl. Acad. Sci. USA, 1993, 90:6444-8 (Exhibit 36).

Affiliated with

Also associated with

Rating

RG1 antibodies and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with RG1 antibodies and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and RG1 antibodies and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4081343